High plasma leptin levels are associated with impaired diastolic function in patients with coronary artery disease

Peptides

Volumn 84, Issue , 2016, Pages 17-21

  Puurunen, V P ^a   Lepojarvi E S ^a   Piira, O P ^a   Hedberg, P ^a,b   Junttila, M J ^a   Ukkola, O ^a   Huikuri, H V ^a  

^a OULU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF OULU   (Finland)

Author keywords

Coronary artery disease; Diastolic function; Heart failure; Leptin; Obesity

Indexed keywords

LEPTIN;

AGED; ARTICLE; CARDIAC IMAGING; CORONARY ARTERY DISEASE; DIASTOLIC DYSFUNCTION; DISEASE ASSOCIATION; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE SIZE; HUMAN; M MODE ECHOCARDIOGRAPHY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; TREND STUDY; TWO DIMENSIONAL ECHOCARDIOGRAPHY; BLOOD; CLINICAL TRIAL; COMPLICATION; DIASTOLE; ECHOCARDIOGRAPHY; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR;

AGED; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; DIASTOLE; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HUMANS; LEPTIN; MALE; MIDDLE AGED; OBESITY; RISK FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84982219432     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2016.08.002     Document Type: Article

References (31)

1. [1] Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., Friedman, J.M., Positional cloning of the mouse obese gene and its human homologue. Nature 372 (1994), 425–432.
2. [2] Maffei, M., Halaas, J., Ravussin, E., Pratley, R.E., Lee, G.H., Zhang, Y., Fei, H., Kim, S., Lallone, R., Ranganathan, S., Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat. Med. 1 (1995), 1155–1161.
3. [3] Mohamed-Ali, V., Pinkney, J.H., Coppack, S.W., Adipose tissue as an endocrine and paracrine organ. Int. J. Obes. Relat. Metab. Disord. 22 (1998), 1145–1158.
4. [4] Sierra-Honigmann, M.R., Nath, A.K., Murakami, C., Garcia-Cardena, G., Papapetropoulos, A., Sessa, W.C., Madge, L.A., Schechner, J.S., Schwabb, M.B., Polverini, P.J., Flores-Riveros, J.R., Biological action of leptin as an angiogenic factor. Science 281 (1998), 1683–1686.
5. [5] Oda, A., Taniguchi, T., Yokoyama, M., Leptin stimulates rat aortic smooth muscle cell proliferation and migration. Kobe J. Med. Sci. 47 (2001), 141–150.
6. [6] Rajapurohitam, V., Gan, X.T., Kirshenbaum, L.A., Karmazyn, M., The obesity-associated peptide leptin induces hypertrophy in neonatal rat ventricular myocytes. Circ. Res. 93 (2003), 277–279.
7. [7] Schulze, P.C., Kratzsch, J., Leptin as a new diagnostic tool in chronic heart failure. Clin. Chim. Acta 362 (2005), 1–11.
8. [8] Ghantous, C.M., Azrak, Z., Hanache, S., Abou-Kheir, W., Zeidan, A., Differential role of leptin and adiponectin in cardiovascular system. Int. J. Endocrinol., 2015, 2015, 534320.
9. [9] Paolisso, G., Tagliamonte, M.R., Galderisi, M., Zito, G.A., Petrocelli, A., Carella C, de Divitiis O, Varricchio M: Plasma leptin level is associated with myocardial wall thickness in hypertensive insulin-resistant men. Hypertension 34 (1999), 1047–1052.
10. [10] Nickola, M.W., Wold, L.E., Colligan, P.B., Wang, G.J., Samson, W.K., Ren, J., Leptin attenuates cardiac contraction in rat ventricular myocytes. Role of NO. Hypertension 36 (2000), 501–505.
11. [11] Zibadi, S., Cordova, F., Slack, E.H., Watson, R.R., Larson, D.F., Leptin's regulation of obesity-induced cardiac extracellular matrix remodeling. Cardiovasc. Toxicol. 11 (2011), 325–333.
12. [12] Leyva, F., Anker, S.D., Egerer, K., Stevenson, J.C., Kox, W.J., Coats, A.J., Hyperleptinaemia in chronic heart failure. Relationships with insulin. Eur. Heart J. 19 (1998), 1547–1551.
13. [13] Schulze, P.C., Kratzsch, J., Linke, A., Schoene, N., Adams, V., Gielen, S., Erbs, S., Moebius-Winkler, S., Schuler, G., Elevated serum levels of leptin and soluble leptin receptor in patients with advanced chronic heart failure. Eur. J. Heart Fail. 5 (2003), 33–40.
14. [14] Abd El-Aziz, T.A., Mohamed, R.H., Mohamed, R.H., Pasha, H.F., Leptin, leptin gene and leptin receptor gene polymorphism in heart failure with preserved ejection fraction. Heart Vessels 27 (2012), 271–279.
15. [15] Fontes-Carvalho, R., Pimenta, J., Bettencourt, P., Leite-Moreira, A., Azevedo, A., Association between plasma leptin and adiponectin levels and diastolic function in the general population. Expert Opin. Ther. Targets 19 (2015), 1283–1291.
16. [16] Pekkanen, M.P., Ukkola, O., Hedberg, P., Piira, O.P., Lepojarvi, S., Lumme, J., Tulppo, M.P., Huikuri HV: Serum 25-hydroxyvitamin D is associated with major cardiovascular risk factors and cardiac structure and function in patients with coronary artery disease. Nutr. Metab. Cardiovasc. Dis. 25 (2015), 471–478.
17. [17] Alpert, M.A., Omran, J., Mehra, A., Ardhanari, S., Impact of obesity and weight loss on cardiac performance and morphology in adults. Prog. Cardiovasc. Dis. 56 (2014), 391–400.
18. [18] Stoddard, M.F., Tseuda, K., Thomas, M., Dillon, S., Kupersmith, J., The influence of obesity on left ventricular filling and systolic function. Am. Heart J. 124 (1992), 694–699.
19. [19] Berkalp, B., Cesur, V., Corapcioglu, D., Erol, C., Baskal, N., Obesity and left ventricular diastolic dysfunction. Int. J. Cardiol. 52 (1995), 23–26.
20. [20] Cil, H., Bulur, S., Turker, Y., Kaya, A., Alemdar, R., Karabacak, A., Aslantas, Y., Ekinozu, I., Albayrak, S., Ozhan, H., Investigators, M.E.L.E.N., Impact of body mass index on left ventricular diastolic dysfunction. Echocardiography 29 (2012), 647–651.
21. [21] Redfield, M.M., Jacobsen, S.J., Burnett, J.C. Jr., Mahoney, D.W., Bailey, K.R., Rodeheffer, R.J., Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 289 (2003), 194–202.
22. [22] Abhayaratna, W.P., Marwick, T.H., Smith, W.T., Becker, N.G., Characteristics of left ventricular diastolic dysfunction in the community: an echocardiographic survey. Heart 92 (2006), 1259–1264.
23. [23] Agata, J., Masuda, A., Takada, M., Higashiura, K., Murakami, H., Miyazaki, Y., Shimamoto, K., High plasma immunoreactive leptin level in essential hypertension. Am. J. Hypertens. 10 (1997), 1171–1174.
24. [24] Chu, N.F., Spiegelman, D., Hotamisligil, G.S., Rifai, N., Stampfer, M., Rimm, E.B., Plasma insulin, leptin, and soluble TNF receptors levels in relation to obesity-related atherogenic and thrombogenic cardiovascular disease risk factors among men. Atherosclerosis 157 (2001), 495–503.
25. [25] Singhal, A., Farooqi, I.S., Cole, T.J., O'Rahilly, S., Fewtrell, M., Kattenhorn, M., Lucas, A., Deanfield, J., Influence of leptin on arterial distensibility: a novel link between obesity and cardiovascular disease?. Circulation 106 (2002), 1919–1924.
26. [26] Konstantinides, S., Schafer, K., Koschnick, S., Loskutoff, D.J., Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity. J. Clin. Invest. 108 (2001), 1533–1540.
27. [27] Wan, S.H., Vogel, M.W., Chen, H.H., Pre-clinical diastolic dysfunction. J. Am. Coll. Cardiol. 63 (2014), 407–416.
28. [28] Zile, M.R., Brutsaert, D.L., New concepts in diastolic dysfunction and diastolic heart failure: part II: causal mechanisms and treatment. Circulation 105 (2002), 1503–1508.
29. [29] Saxena, N.K., Ikeda, K., Rockey, D.C., Friedman, S.L., Anania, F.A., Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice. Hepatology 35 (2002), 762–771.
30. [30] Wolf, G., Ziyadeh, F.N., Leptin and renal fibrosis. Contrib. Nephrol. 151 (2006), 175–183.
31. [31] Bornstein, S.R., Torpy, D.J., Leptin and the renin-angiotensin-aldosterone system. Hypertension 32 (1998), 376–377.